Exons 9-11 of Gba (glucosidase, beta, acid) are flanked by loxP sites in this conditional model, useful in studies of Gaucher disease.
Lorne A Clarke, University of British Columbia
Genetic Background | Generation |
---|---|
|
Allele Type | Gene Symbol | Gene Name |
---|---|---|
Targeted (Conditional ready (e.g. floxed), No functional change) | Gba | glucosidase, beta, acid |
Inherited deficiency of the lysosomal hydrolase, glucocerebrosidase (encoded by Gba, glucosidase, beta, acid) underlies the autosomal recessive disorder, Gaucher disease. Excessive glucocerebroside storage may lead to the associated tissue dysfunctions. Affected individuals present with a spectrum of clinical symptoms ranging from hepatosplenomegaly, haematological abnormalities, and bone pain, to severe neurodegeneration and premature death. Homozygous knockouts of Gba in mice are perinatal lethal.
In this targeted allele, exons 9-11 are flanked by loxP sites enabling tissue-directed knockouts of the locus via Cre excision. Incomplete expression of Tie2Cre-recombinase (see Stock No. 004128) in cells of hematopoietic and endothelial origin results in deficiency of glucocerebrosidase in the liver, spleen, bone marrow, and peripheral white cells. Glucocerebroside storage in this model leads to progressive splenomegaly with Gaucher cell infiltration and modest storage in the liver by 26 weeks of age. No animals displayed obvious pathology in the bone marrow by 26 weeks of age, but small numbers of Gaucher cells could be found. No obvious haematological differences were seen in affected animals at 26 weeks of age.
LysMCre (see Stock No. 004781) and EIIaCre (see Stock No. 003724) conditional knockout mice fail to develop any notable pathology in the liver, spleen, and bone marrow by 26 weeks of age.
A targeting vector was designed to place loxP sites on either side of Gba exons 9-11 and place an FRT-flanked neomycin cassette in reverse transcriptional orientation in intron 11. The targeting vector was injected into (129X1/SvJ x 129S1/Sv)F1- Kitl+-derived R1 embryonic stem (ES) cells. A Flpe-recombinase expression plasmid was introduced to targeted ES cells by electroporation to remove the neomycin resistance cassette. This strain was backcrossed to C57BL/6J for 11 generations by the donating laboratory.
Allele Name | targeted mutation 1, Lorne A Clarke |
---|---|
Allele Type | Targeted (Conditional ready (e.g. floxed), No functional change) |
Allele Synonym(s) | FloxGBA |
Gene Symbol and Name | Gba, glucosidase, beta, acid |
Gene Synonym(s) | |
Strain of Origin | (129X1/SvJ x 129S1/Sv)F1-Kitl+ |
Chromosome | 3 |
Molecular Note | A targeting vector was designed to flank exons 9-11 with loxP sites. An frt-flanked neo was inserted as well as exons 8-4 of metaxin 1 in reverse orientation. The neo was removed by transient expression of FLP recombinase. |
Homozygous and heterozygous floxed mice are viable and fertile.
When using the FloxGBA mouse strain in a publication, please cite the originating article(s) and include JAX stock #021329 in your Materials and Methods section.
Facility Barrier Level Descriptions
Service/Product | Description | Price |
---|---|---|
Heterozygous for Gba<tm1Clk> |
Frozen Mouse Embryo | B6.129-Gba<tm1Clk>/J Frozen Embryo | $2595.00 |
Frozen Mouse Embryo | B6.129-Gba<tm1Clk>/J Frozen Embryo | $2595.00 |
Frozen Mouse Embryo | B6.129-Gba<tm1Clk>/J Frozen Embryo | $3373.50 |
Frozen Mouse Embryo | B6.129-Gba<tm1Clk>/J Frozen Embryo | $3373.50 |
Terms are granted by individual review and stated on the customer invoice(s) and account statement. These transactions are payable in U.S. currency within the granted terms. Payment for services, products, shipping containers, and shipping costs that are rendered are expected within the payment terms indicated on the invoice or stated by contract. Invoices and account balances in arrears of stated terms may result in The Jackson Laboratory pursuing collection activities including but not limited to outside agencies and court filings.
The Jackson Laboratory has rigorous genetic quality control and mutant gene genotyping programs to ensure the genetic background of JAX® Mice strains as well as the genotypes of strains with identified molecular mutations. JAX® Mice strains are only made available to researchers after meeting our standards. However, the phenotype of each strain may not be fully characterized and/or captured in the strain data sheets. Therefore, we cannot guarantee a strain's phenotype will meet all expectations. To ensure that JAX® Mice will meet the needs of individual research projects or when requesting a strain that is new to your research, we suggest ordering and performing tests on a small number of mice to determine suitability for your particular project. We do not guarantee breeding performance and therefore suggest that investigators order more than one breeding pair to avoid delays in their research.
What information were you hoping to find through your search?
How easy was it to find what you were looking for?
We may wish to follow up with you. Enter your email if you are happy for us to connect and reachout to you with more questions.
Please Enter a Valid Email Address
Thank you for sharing your feedback! We are working on improving the JAX Mice search. Come back soon for exciting changes.